These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 1855673)

  • 1. Oxidative status and oral contraceptive. Its relevance to platelet abnormalities and cardiovascular risk.
    Ciavatti M; Renaud S
    Free Radic Biol Med; 1991; 10(5):325-38. PubMed ID: 1855673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haemostatic changes and the oral contraceptive pill.
    Norris LA; Bonnar J
    Baillieres Clin Obstet Gynaecol; 1997 Sep; 11(3):545-64. PubMed ID: 9488791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral contraception and coagulation.
    Notelovitz M
    Clin Obstet Gynecol; 1985 Mar; 28(1):73-83. PubMed ID: 3987135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coagulation and anticoagulation effects of contraceptive steroids.
    Samsioe G
    Am J Obstet Gynecol; 1994 May; 170(5 Pt 2):1523-7. PubMed ID: 8178901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical aspects of the relationship between oral contraceptives and abnormalities of the hemostatic system: relation to the development of cardiovascular disease.
    Kelleher CC
    Am J Obstet Gynecol; 1990 Jul; 163(1 Pt 2):392-5. PubMed ID: 2196811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral contraceptives, clotting factors, and thrombosis.
    Meade TW
    Am J Obstet Gynecol; 1982 Mar; 142(6 Pt 2):758-61. PubMed ID: 6801980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contraceptive steroid effects on nonreproductive organ systems.
    Corson SL
    J Reprod Med; 1986 Sep; 31(9 Suppl):865-78. PubMed ID: 3772906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.
    Roy S; Mishell DR; Gray G; Dozono-Takano R; Brenner PF; Eide I; de Quattro V; Shaw ST
    Am J Obstet Gynecol; 1980 Apr; 136(7):920-31. PubMed ID: 6767404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of smoking on prostacyclin formation and platelet aggregation in users of oral contraceptives.
    Roy S
    Am J Obstet Gynecol; 1999 Jun; 180(6 Pt 2):S364-8. PubMed ID: 10368522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contraceptive choices in women with coagulation disorders.
    Comp PC; Zacur HA
    Am J Obstet Gynecol; 1993 Jun; 168(6 Pt 2):1990-3. PubMed ID: 8512043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cardiovascular risks of oral contraceptives: dose-response relationship].
    Kelleher CC
    Contracept Fertil Sex (Paris); 1991 Apr; 19(4):285-8. PubMed ID: 12343220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Smoking and use of oral contraceptives: impact on thrombotic diseases.
    Lidegaard O
    Am J Obstet Gynecol; 1999 Jun; 180(6 Pt 2):S357-63. PubMed ID: 10368521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study of the interactive effects of oral contraceptive use and dietary fat intake on blood pressure, cardiovascular reactivity and glucose tolerance in normotensive women.
    Straznicky NE; Barrington VE; Branley P; Louis WJ
    J Hypertens; 1998 Mar; 16(3):357-68. PubMed ID: 9557929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two problems in oral contraception: arteriosclerotic cardiopathy and drug interactions.
    Onnis A; Grella PV; Di Lenardo L
    Clin Exp Obstet Gynecol; 1982; 9(2):61-5. PubMed ID: 7160061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complications and contraindications of oral contraception.
    Beck WW
    Clin Obstet Gynecol; 1981 Sep; 24(3):893-901. PubMed ID: 7026110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of thromboxane A2 in increased whole blood platelet aggregation in oral contraceptive users.
    Norris LA; Devitt M; Bonnar J
    Thromb Res; 1996 Feb; 81(4):407-17. PubMed ID: 8907290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of vitamin E administration on platelet functions in hormonal contraceptive users.
    Renaud S; Ciavatti M; Perrot L; Berthezene F; Dargent D; Condamin P
    Contraception; 1987 Sep; 36(3):347-58. PubMed ID: 3677678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for coronary heart disease and platelet functions.
    Renaud S
    Adv Exp Med Biol; 1984; 164():129-44. PubMed ID: 6695570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on oral contraception.
    Rabe T; Runnebaum B
    Eur J Obstet Gynecol Reprod Biol; 1993 Apr; 49(1-2):10-2. PubMed ID: 8365502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An epidemiologic survey of cardiovascular disease in women taking oral contraceptives.
    Thorogood M; Vessey MP
    Am J Obstet Gynecol; 1990 Jul; 163(1 Pt 2):274-81. PubMed ID: 2196799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.